Neuroscience News

Juliet Knowles's research has recently shown that the brain can use adaptive myelination to perfect “skills” that are actually pathological, such as having s

Stanford Medicine research demonstrates a new way of detecting cells implicated in the malfunctions that cause psychiatric diseases.

Stanford University researchers have released a groundbreaking virtual reality (VR) application designed to help children prepare f

Researchers at Stanford’s Knight Initiative for Brain Resilience merge spatial transcriptomics and AI to uncover how local cellular interactions drive brain aging and resilience

Join us as we look back on some of the key studies we covered here at Wu Tsai Neuro in 2024 to give a (very partial) overview of the impact of our community’s research efforts this past year

New research shows aging is not a uniform process. Parts of our bodies start aging earlier than others, right down to our organs and cells.

Fat-filled microglia may play a role in the damage caused by Alzheimer’s, especially for those who carry two copies a particular gene.

We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression.

With Knight Initiative support, Stanford researchers uncover a biochemical “off-ramp” in ketosis, rewriting our understanding of how ketosis influences metabolism.

Supported by the Big Ideas in Neuroscience program, research from the Brunet lab suggests the possibility of designing pharmaceutical or genetic therapies to turn on new neuron production in old or injured brains.

Wu Tsai Neuro affiliate Carolyn Rodriguez directs the Stanford OCD Research Lab.

With support from a Wu Tsai Neuro seed grant, faculty affiliate Helen Bronte-Stewart and her team have developed a simple, portable device to help Parkinson'

Research projects funded by the Wu Tsai Neurosciences Institute's Synthetic Neuroscience Grants will advance molecular and tissue engineering tools to more precisely study and interact with brain circuits.

This week on From Our Neurons to Yours, we talk with Stanford neurologist Mike Greicius about his critique of new amyloid-clearing Alzheimer's drugs, and his optimism for the next wave of therapies currently in development.

New research by Institute affiliate Leanne Williams adds to the evidence that choosing treatment based on the neurological underpinnings of a patient’s depre

This week on From Our Neurons to Yours, we talk with Leanne Williams about distinctive biotypes of depression revealed by brain imaging and AI, and the implications for therapy and mental health.